세계의 국소 약물전달 시장 - 규모, 점유율, 성장 분석 : 제품별, 투여 경로별, 사용 시설별, 지역별 산업 예측(2024-2031년)
Topical Drug Delivery Market Size, Share, Growth Analysis, By Product, By Route of Administration, By Facility of Use, By Region - Industry Forecast 2024-2031
상품코드:1619059
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2024년 12월
페이지 정보:영문 157 Pages
라이선스 & 가격 (부가세 별도)
한글목차
국소 약물 전달 세계 시장 규모는 2022년에 2,078억 5,000만 달러로 평가되었고, 2023년 2,267억 6,000만 달러에서 2031년에는 4,551억 7,000만 달러로 성장해 예측 기간(2024-2031년) CAGR은 9.1%로 성장할 전망입니다.
세계의 국소 약물 전달 시장은 여드름, 건선, 습진, 피부염 등 적목적 치료가 필요한 피부 질환의 유병률 증가에 견인되어 현저한 성장을 이루고 있습니다. 화염과 당뇨병 궤양과 같은 만성 문제에 직면하는 노인 인구와 결합하여 효과적인 치료 옵션에 대한 수요가 증가함에 따라 이러한 비 침습적 전달 시스템의 채택 속도가 빨라집니다. 국소 약물 전달은 통증 관리 및 상처 치유를 촉진할뿐만 아니라 레티노이드와 히알루론산과 같은 노화의 징후에 대항하는 데 중요한 활성 성분입니다. 또한, 미용 피부과학에 대한 관심 증가가 국소 전달 기술의 혁신에 박차를 가하고 있어, 이 시장은 향후 수년간 지속적으로 확대할 것으로 보입니다.
목차
소개
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터의 방법
시장 규모 예측
시장의 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
억제요인과 과제
Porter's Five Forces 분석
주요 시장 인사이트
중요성공요인
경쟁도
주요 투자 기회
시장 생태계
시장의 매력 지수(2023년)
PESTEL 분석
거시경제지표
밸류체인 분석
가격 분석
특허 분석
규제 분석
기술 분석
국소 약물전달 시장 규모 : 제품별 및 CAGR(2024-2031년)
시장 개요
반고형 제제
연고
크림
로션
젤
페이스트
액체 제형
서스펜션
솔루션
고형 제제
분말
좌약
경피 흡수 제품
경피 패치
경피 흡수형 반고형제
국소 약물 전달 시장 규모 : 투여 경로별 및 CAGR(2024-2031년)
시장 개요
피부 약물전달
안과 약물 전달
질 약물 전달
직장 약물 전달
코 약물전달
국소 약물전달 시장 규모 : 사용시설별 및 CAGR(2024-2031년)
시장 개요
가정치료 환경
병원 및 클리닉
화상 센터
기타 시설
국소 약물 전달 시장 규모 및 CAGR(2024-2031년)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카
기타 중동 및 아프리카
경쟁 정보
상위 5개사 비교
주요 기업의 시장 포지셔닝(2023년)
주요 시장 기업이 채용한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2023년)
주요 기업의 기업 프로파일
기업 개요
제품 포트폴리오 분석
부문별 점유율 분석
수익의 전년대비 비교(2021-2023년)
주요 기업 프로파일
Glenmark Pharmaceuticals Ltd.(India)
Galderma(Switzerland)
Johnson & Johnson Private Limited(US)
GlaxoSmithKline Plc.(UK)
Bausch Health Companies Inc.(Canada)
Hisamitsu Pharmaceuticals Inc.(Japan)
Cipla(India)
Bayer AG(Germany)
Viatris Inc.(Mylan NV)(US)
3M(US)
Merck & Co., Inc.(Germany)
Crescita Therapeutics Inc.(캐나다)
Novartis International AG(Switzerland)
Boehringer Ingelheim International GmbH(Germany)
Pfizer Inc.(US)
Teva Pharmaceuticals Industries Ltd.(Israel)
Bristol Myers Squibb(US)
Lead Chemical Co., Ltd.(Japan)
Purdue Pharma LP(US)
Lavipharm(Greece)
결론과 권장사항
JHS
영문 목차
영문목차
Global Topical Drug Delivery Market size was valued at USD 207.85 billion in 2022 and is poised to grow from USD 226.76 billion in 2023 to USD 455.17 billion by 2031, growing at a CAGR of 9.1% during the forecast period (2024-2031).
The global topical drug delivery market has seen remarkable growth, driven by the increasing prevalence of skin conditions such as acne, psoriasis, eczema, and dermatitis that necessitate targeted treatment. The rising demand for effective treatment options, coupled with an aging population facing chronic issues like arthritis and diabetic ulcers, has accelerated the adoption of these non-invasive delivery systems. Topical drug delivery not only facilitates pain management and wound healing but also enhances the delivery of active ingredients, such as retinoids and hyaluronic acid, crucial for combating signs of aging. Additionally, the surge in cosmetic dermatology interest has spurred innovation in topical delivery technologies, positioning this market for sustained expansion in the coming years.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Topical Drug Delivery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Topical Drug Delivery Market Segmental Analysis
Global Topical Drug Delivery Market is segmented by product, route of administration, facility of use and region. Based on product, the market is segmented into semi-solid formulations, liquid formulations, solid formulations and transdermal products. Based on route of administration, the market is segmented into dermal drug delivery, ophthalmic drug delivery, vaginal drug delivery, rectal drug delivery and nasal drug delivery. Based on facility of use, the market is segmented into homecare settings, hospitals & clinics, burn centers and other facilities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Topical Drug Delivery Market
The Global Topical Drug Delivery market is significantly driven by the convenience and non-invasive nature of this method for administering medications. By providing an alternative to injections and oral dosage forms, topical drug delivery appeals to patients who experience anxiety around needles or seek a more comfortable and straightforward treatment process. This ease of use not only improves patient adherence to prescribed therapies but also enhances the overall treatment experience. This method is particularly beneficial for children and individuals with a fear of needles, making topical formulations a favored choice in contemporary healthcare.
Restraints in the Global Topical Drug Delivery Market
The Global Topical Drug Delivery market faces significant restraints primarily due to formulation challenges that arise during the development of stable and effective topical products. Key factors such as drug solubility, stability, and compatibility with excipients complicate the formulation process, necessitating a delicate balance to achieve the desired release profile. These complexities can affect the overall availability and commercial success of topical drug formulations, as they must comply with rigorous quality standards and regulatory requirements while also ensuring that they deliver optimal therapeutic efficacy. Consequently, these formulation challenges pose a barrier to innovation and market growth in the sector.
Market Trends of the Global Topical Drug Delivery Market
The Global Topical Drug Delivery market is witnessing robust growth, propelled by the rising incidence of skin diseases and an ageing population that demands effective treatment options. The shift towards non-invasive drug delivery methodologies enhances patient compliance and accessibility, further fueling market expansion. Innovative technologies like microneedles and nanocarriers are enhancing drug efficacy and penetration, creating new avenues for growth. However, challenges such as high product costs and stringent regulatory hurdles could impede progress. Despite these obstacles, the market remains optimistic, driven by continuous technological advancements and growing awareness of the benefits of topical drug administration.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Patent Analysis
Regulatory Analysis
Technology Analysis
Global Topical Drug Delivery Market Size by Product & CAGR (2024-2031)
Market Overview
Semi-Solid Formulations
Ointments
Creams
Lotions
Gels
Pastes
Liquid Formulations
Suspensions
Solutions
Solid Formulations
Powders
Suppositories
Transdermal Products
Transdermal Patches
Transdermal Semi-Solids
Global Topical Drug Delivery Market Size by Route Of Administration & CAGR (2024-2031)
Market Overview
Dermal Drug Delivery
Ophthalmic Drug Delivery
Vaginal Drug Delivery
Rectal Drug Delivery
Nasal Drug Delivery
Global Topical Drug Delivery Market Size by Facility Of Use & CAGR (2024-2031)
Market Overview
Homecare Settings
Hospitals & Clinics
Burn Centers
Other Facilities
Global Topical Drug Delivery Market Size & CAGR (2024-2031)
North America (Product, Route Of Administration, Facility Of Use)
USA
Canada
Europe (Product, Route Of Administration, Facility Of Use)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Product, Route Of Administration, Facility Of Use)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Product, Route Of Administration, Facility Of Use)
Brazil
Rest of Latin America
Middle East & Africa (Product, Route Of Administration, Facility Of Use)
